Dow AgroSciences posts small NZ loss
Dow AgroSciences (New Zealand) turned to a loss in 2011, partly reflecting difficulty in sourcing raw materials for its weed and pest control products because of strong demand for agricultural chemicals in the US and Latin America.
The net loss was $742,000 in calendar 2011, from a profit of $6.8 million a year earlier, the New Plymouth-based company said in its annual financial report. Sales fell 13 percent to $119 million.
Dow AgroSciences NZ is ultimately owned by New York Stock Exchange-listed Dow Chemical, the biggest US chemical company by revenue. The local business, formerly known as Ivon Watkins Dow, sells products including Grazon and Tordon herbicide and Delegate insecticide through rural merchants in New Zealand and distribution retailers in Australia.
“There was a significant shortage of key raw materials we source from outside Australia and New Zealand,” said Andrew Syme, the company’s regional supply chain manager. “Global demand for agri-chemicals has been very strong. With commodity crop prices reasonably high, farmers are more willing to invest in the yield of their crop.”
The annual report cited difficulty in obtaining “2,4D acid raw materials to meet demand.” The New Zealand company also had to deal with a disruption to production from an unexpected two-month shutdown due to an accident, the report said.
Foreign exchange losses were $416,000, down from a loss of $1.85 million a year earlier, it said.
Syme said the company has made changes to its sourcing policy to minimise future disruptions. So far in 2012, demand “continues to be strong” and crop prices “continue to be high.”
Comments from our readers
No comments yet
Add your comment:
DNZ annual earnings fall 14 percent, signals $80M capital raising for new acquisitions
Vodafone NZ loses mobile customers for 9th straight quarter
Minnow lender Asset Finance rapped by RBNZ over related party lending
NZ dollar weakens ahead of Federal Reserve comments on stimulus
While you were sleeping Bullard lifts stocks
NZ inflation expectations fall to lowest since June 1999 as growth uptick seen
F and P Healthcare shares rise to two-year high as First NZ raises rating on better outlook
Deep-sea phosphate miner CRP on track for final investment decision this year
Renaissance posts first-half loss on shrinking margins from Apple products, impairment
Central Plains Water shareholders committed to capital raising up to $56 mln